DeepMed Research

University Hospital of Brest

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation

Phase 3

Completed

Conditions: Renal Transplant

Interventions: Drug: Anti R-IL2 + Cyclosporine
Drug: Anti R-IL2 + Cyclosporine then Everolimus
Drug: Thymoglobulin + Everolimus

First Posted Date: 2009-12-09

Last Posted Date: 2014-07-08

Lead Sponsor: University Hospital, Brest

Target Recruit Count: 327

Registration Number: NCT01028092

Locations: 🇫🇷
CHU Pellegrin - Bordeaux, Bordeaux, France
🇫🇷
CHU Cote de Nacre, Caen, France
🇫🇷
CHU Limoges, Limoges, France

and more 15 locations

Merits of Continuous Paravertebral Block in the Management of Renal/Adrenal Surgery by Laparotomy

Not Applicable

Terminated

Conditions: Indication for Renal and/or Adrenal Surgery

Interventions: Procedure: Continuous Paravertebral block

First Posted Date: 2009-12-02

Last Posted Date: 2014-07-30

Lead Sponsor: University Hospital, Brest

Target Recruit Count: 41

Registration Number: NCT01023854

Locations: 🇫🇷
Cavale Blanche Hospital, Brest, France

Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a Vein

Not Applicable

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Thromboembolism

Interventions: Procedure: diagnostic procedure
Radiation: fludeoxyglucose F 18

First Posted Date: 2009-08-24

Last Posted Date: 2014-12-08

Lead Sponsor: University Hospital, Brest

Target Recruit Count: 400

Registration Number: NCT00964275

Locations: 🇫🇷
CHU Brest - Hopital De La Cavale Blanche, Brest, France

Benign Acute Pericarditis: Brief Versus Longer Treatment Using Aspirin

Phase 4

Terminated

Conditions: Pericarditis

Interventions: Drug: placebo
Drug: Aspirin

First Posted Date: 2009-07-27

Last Posted Date: 2011-12-21

Lead Sponsor: University Hospital, Brest

Target Recruit Count: 34

Registration Number: NCT00946907

Locations: 🇫🇷
CHG Carhaix, Carhaix, France
🇫🇷
HIA Clermont Tonnerre, Brest, France
🇫🇷
CHG Douarnenez, Douarnenez, France

and more 9 locations

Pemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC)

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: Pemetrexed, cisplatin

First Posted Date: 2008-09-01

Last Posted Date: 2009-07-28

Lead Sponsor: University Hospital, Brest

Target Recruit Count: 45

Registration Number: NCT00744900

Locations: 🇫🇷
CHI, Service de Pneumologie, Creteil, France
🇫🇷
CHU d'Angers, Service de Pneumologie, Angers, France
🇫🇷
CHU brest, institut de cancérologie et d'hématologie, Brest, France

and more 22 locations

Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study.

Phase 3

Completed

Conditions: Pulmonary Embolism

Interventions: Drug: placebo of warfarin
Drug: warfarin

First Posted Date: 2008-08-25

Last Posted Date: 2017-01-12

Lead Sponsor: University Hospital, Brest

Target Recruit Count: 374

Registration Number: NCT00740883

Locations: 🇫🇷
Brest University Hospital, Brest, France

Single Complete Compression Ultrasonography to Rule Out Deep Vein Thrombosis During Pregnancy and Postpartum

Completed

Conditions: Deep Vein Thrombosis

Interventions: Other: Lower limb veins compression ultrasonography

First Posted Date: 2008-08-25

Last Posted Date: 2025-02-05

Lead Sponsor: University Hospital, Brest

Target Recruit Count: 200

Registration Number: NCT00740454

Locations: 🇨🇭
Division of Angiology and Hemostasis, Geneva University Hospital, Geneva, Switzerland
🇫🇷
EA3878, Brest University Hospital, Brest, France

Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.

Phase 4

Completed

Conditions: Rotavirus Gastroenteritis

Interventions: Biological: Rotateq vaccine

First Posted Date: 2008-08-25

Last Posted Date: 2013-10-22

Lead Sponsor: University Hospital, Brest

Target Recruit Count: 7204

Registration Number: NCT00740935

Locations: 🇫🇷
Clinical Investigation Center, Brest, France

Tolerance and Efficacy of Rituximab in Sjogren's Disease

Phase 2

Completed

Conditions: Sjogren's Disease

Interventions: Drug: Rituximab (mabthera) Injection

First Posted Date: 2008-08-25

Last Posted Date: 2025-02-05

Lead Sponsor: University Hospital, Brest

Target Recruit Count: 122

Registration Number: NCT00740948

Locations: 🇫🇷
CHU de Marseille, Marseille, France
🇫🇷
CHU de Brest, Brest, France
🇫🇷
CHU Clermont-Ferrand, Clermont-ferrand, France

and more 11 locations

Efficacy of Intermittent Pneumatic Compression (IPC) on Venous Thromboembolism Incidence in Intensive Care Unit (ICU) Patients With High Bleeding Risk

Phase 3

Completed

Conditions: High Bleeding Risk
Hemorrhage

Interventions: Device: Intermittent pneumatic compression of the lower limbs

First Posted Date: 2008-08-25

Last Posted Date: 2012-02-14

Lead Sponsor: University Hospital, Brest

Target Recruit Count: 408

Registration Number: NCT00740844

Locations: 🇫🇷
Intensive Care Unit, Limoges, France
🇫🇷
HIA Clermont-Tonnerre, Brest, France
🇫🇷
Medical intensive care unit, Tours, France

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy